Cargando…
Benchmark for Time in Therapeutic Range in Venous Thromboembolism: A Systematic Review and Meta-Analysis
INTRODUCTION: The percentage of time within the target INR range 2.0 to 3.0 (TTR) in patients treated with vitamin K antagonists varies considerably among efficacy-studies of novel anticoagulants. In order to properly asses the quality of anticoagulant control in upcoming cost-effectiveness studies...
Autores principales: | Erkens, Petra M. G., ten Cate, Hugo, Büller, Harry R., Prins, Martin H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458058/ https://www.ncbi.nlm.nih.gov/pubmed/23049730 http://dx.doi.org/10.1371/journal.pone.0042269 |
Ejemplares similares
-
Secondary prophylaxis decision‐making in venous thromboembolism: interviews on clinical practice in thirteen countries
por: Ten Cate, Vincent, et al.
Publicado: (2017) -
Prevalence of venous obstructions in (recurrent) venous thromboembolism: a case-control study
por: Notten, Pascale, et al.
Publicado: (2020) -
Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment
por: Ten Cate, Vincent, et al.
Publicado: (2017) -
Predicting Recurrent Venous Thromboembolism in Patients With Deep-Vein Thrombosis: Development and Internal Validation of a Potential New Prediction Model (Continu-8)
por: Nagler, Michael, et al.
Publicado: (2021) -
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2019)